News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
drugs pills and capsules

Phase 3 study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013)

Presented at the American Society of Clinical Oncology annual conference, researchers from Japan found doublet chemo with S-1 and cisplatin (CS) first-line chemo improved survival for advanced gastric cancer patients compared with CS alone. They also found the addition of docetaxel to CS did not improve survival for patients with untreated advanced gastric cancer.

Read Source
DonateMore InfoDonateMore Info
We cannot gather at a gala event this year, but a pandemic cannot stop us from joining together to ensure that the search to find a cure for gastric (stomach) cancer continues.

Join with us to fuel the next wave of progress.

Every contribution moves us closer to a cure.
Please join with us to fuel the next wave of progress. Together, we will defeat stomach cancer.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.